Loading…
Based on limited metadata, the FDA issued a Warning Letter to KOI CBD LLC on November 22, 2019, regarding products classified as "Other" (likely CBD-containing products). Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning was issued by the FDA, though the specific issuing office is not identified in this metadata. To understand the actual compliance concerns and required corrective actions, the complete Warning Letter would need to be reviewed.